IDEAS home Printed from https://ideas.repec.org/a/eee/respol/v50y2021i2s0048733320302298.html
   My bibliography  Save this article

Bridging the gap between invention and innovation: Increasing success rates in publicly and industry-funded clinical trials

Author

Listed:
  • Haeussler, Carolin
  • Assmus, Anne

Abstract

While basic research in the natural sciences can generate discoveries with great promise to improve human health, advancing these discoveries from bench to bedside through clinical trials is a major challenge requiring individuals to possess a specific set of skills and prior experience. The ability to translate—especially between basic and applied research—and to bridge these two areas is likely to be key. We call skills that encompass both basic and applied research horizontal skills; experience in diverse fields, such as both cancer and diabetes, is termed vertical experience. We develop a framework to define and differentiate between horizontal skills and vertical experience and discuss how they separately and jointly impact the success of turning discoveries into products. Drawing on data from 3,889 clinical trials, we find that both qualities matter for publicly funded and industry-funded trials but with nuanced differences. Our results suggest that the likelihood of success increases when the investigators who lead trials have a balanced set of skills in both basic and applied science independent of the funding source. In both types of trials, investigators who possess vertical experience were found to reduce the success probability of clinical trials. However, investigators in industry-funded trials are able to alleviate this effect if they possess basic research skills or horizontal skills. Our paper uncovers context specificities in terms of how horizontal skills and experience in multiple fields, as well as their interplay, relate to translational success.

Suggested Citation

  • Haeussler, Carolin & Assmus, Anne, 2021. "Bridging the gap between invention and innovation: Increasing success rates in publicly and industry-funded clinical trials," Research Policy, Elsevier, vol. 50(2).
  • Handle: RePEc:eee:respol:v:50:y:2021:i:2:s0048733320302298
    DOI: 10.1016/j.respol.2020.104155
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0048733320302298
    Download Restriction: Full text for ScienceDirect subscribers only

    File URL: https://libkey.io/10.1016/j.respol.2020.104155?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Benjamin F. Jones, 2009. "The Burden of Knowledge and the "Death of the Renaissance Man": Is Innovation Getting Harder?," The Review of Economic Studies, Review of Economic Studies Ltd, vol. 76(1), pages 283-317.
    2. Paul R. Carlile, 2004. "Transferring, Translating, and Transforming: An Integrative Framework for Managing Knowledge Across Boundaries," Organization Science, INFORMS, vol. 15(5), pages 555-568, October.
    3. Jeff S. Armstrong & Michael R. Darby & Lynne G. Zucker, 2003. "Commercializing knowledge: university science, knowledge capture and firm performance in biotechnology," Proceedings, Federal Reserve Bank of Dallas, issue Sep, pages 149-170.
    4. McMillan, G. Steven & Narin, Francis & Deeds, David L., 2000. "An analysis of the critical role of public science in innovation: the case of biotechnology," Research Policy, Elsevier, vol. 29(1), pages 1-8, January.
    5. Ali, Ayfer & Gittelman, Michelle, 2016. "Research paradigms and useful inventions in medicine: Patents and licensing by teams of clinical and basic scientists in Academic Medical Centers," Research Policy, Elsevier, vol. 45(8), pages 1499-1511.
    6. Nelson, Richard R., 2003. "On the uneven evolution of human know-how," Research Policy, Elsevier, vol. 32(6), pages 909-922, June.
    7. Pierre Azoulay, 2004. "Capturing Knowledge within and across Firm Boundaries: Evidence from Clinical Development," American Economic Review, American Economic Association, vol. 94(5), pages 1591-1612, December.
    8. Haeussler, Carolin & Sauermann, Henry, 2020. "Division of labor in collaborative knowledge production: The role of team size and interdisciplinarity," Research Policy, Elsevier, vol. 49(6).
    9. Gautam Ahuja & Curba Morris Lampert, 2001. "Entrepreneurship in the large corporation: a longitudinal study of how established firms create breakthrough inventions," Strategic Management Journal, Wiley Blackwell, vol. 22(6‐7), pages 521-543, June.
    10. Henry Sauermann & Paula Stephan, 2013. "Conflicting Logics? A Multidimensional View of Industrial and Academic Science," Organization Science, INFORMS, vol. 24(3), pages 889-909, June.
    11. Partha, Dasgupta & David, Paul A., 1994. "Toward a new economics of science," Research Policy, Elsevier, vol. 23(5), pages 487-521, September.
    12. Nathan ROSENBERG, 2009. "Why do firms do basic research (with their own money)?," World Scientific Book Chapters, in: Nathan Rosenberg (ed.), Studies On Science And The Innovation Process Selected Works of Nathan Rosenberg, chapter 11, pages 225-234, World Scientific Publishing Co. Pte. Ltd..
    13. John E. Brandl & Laurence E. Lynn, 1998. "Pasteur's Quadrant: Basic science and technological innovation," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 17(4), pages 734-736.
    14. Pierre Azoulay & Joshua S. Graff Zivin & Jialan Wang, 2010. "Superstar Extinction," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 125(2), pages 549-589.
    15. Francisco Polidoro & Matt Theeke, 2012. "Getting Competition Down to a Science: The Effects of Technological Competition on Firms' Scientific Publications," Organization Science, INFORMS, vol. 23(4), pages 1135-1153, August.
    16. Rebecca Henderson & Iain Cockburn, 1996. "Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery," RAND Journal of Economics, The RAND Corporation, vol. 27(1), pages 32-59, Spring.
    17. James G. March, 1991. "Exploration and Exploitation in Organizational Learning," Organization Science, INFORMS, vol. 2(1), pages 71-87, February.
    18. Danzon, Patricia M. & Nicholson, Sean & Pereira, Nuno Sousa, 2005. "Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances," Journal of Health Economics, Elsevier, vol. 24(2), pages 317-339, March.
    19. Andrew A. Toole & Dirk Czarnitzki, 2009. "Exploring the Relationship Between Scientist Human Capital and Firm Performance: The Case of Biomedical Academic Entrepreneurs in the SBIR Program," Management Science, INFORMS, vol. 55(1), pages 101-114, January.
    20. Lynne G. Zucker & Michael R. Darby, 2007. "Virtuous circles in science and commerce," Papers in Regional Science, Wiley Blackwell, vol. 86(3), pages 445-470, August.
    21. Lori Rosenkopf & Atul Nerkar, 2001. "Beyond local search: boundary‐spanning, exploration, and impact in the optical disk industry," Strategic Management Journal, Wiley Blackwell, vol. 22(4), pages 287-306, April.
    22. Rosenberg, Nathan & Nelson, Richard R., 1994. "American universities and technical advance in industry," Research Policy, Elsevier, vol. 23(3), pages 323-348, May.
    23. Alexander Oettl, 2012. "Reconceptualizing Stars: Scientist Helpfulness and Peer Performance," Management Science, INFORMS, vol. 58(6), pages 1122-1140, June.
    24. Deborah Dougherty & Danielle D. Dunne, 2012. "Digital Science and Knowledge Boundaries in Complex Innovation," Organization Science, INFORMS, vol. 23(5), pages 1467-1484, October.
    25. Pavitt, Keith, 1991. "What makes basic research economically useful?," Research Policy, Elsevier, vol. 20(2), pages 109-119, April.
    26. Thursby, Jerry G & Jensen, Richard & Thursby, Marie C, 2001. "Objectives, Characteristics and Outcomes of University Licensing: A Survey of Major U.S. Universities," The Journal of Technology Transfer, Springer, vol. 26(1-2), pages 59-72, January.
    27. Lee Fleming & Olav Sorenson, 2004. "Science as a map in technological search," Strategic Management Journal, Wiley Blackwell, vol. 25(8‐9), pages 909-928, August.
    28. Llopis, Oscar & D’Este, Pablo, 2016. "Beneficiary contact and innovation: The relation between contact with patients and medical innovation under different institutional logics," Research Policy, Elsevier, vol. 45(8), pages 1512-1523.
    29. Robert S. Huckman & Darren E. Zinner, 2008. "Does focus improve operational performance? Lessons from the management of clinical trials," Strategic Management Journal, Wiley Blackwell, vol. 29(2), pages 173-193, February.
    30. Beth A. Bechky, 2003. "Sharing Meaning Across Occupational Communities: The Transformation of Understanding on a Production Floor," Organization Science, INFORMS, vol. 14(3), pages 312-330, June.
    31. Michelle Gittelman & Bruce Kogut, 2003. "Does Good Science Lead to Valuable Knowledge? Biotechnology Firms and the Evolutionary Logic of Citation Patterns," Management Science, INFORMS, vol. 49(4), pages 366-382, April.
    32. Ha Hoang & Frank T. Rothaermel, 2010. "Leveraging internal and external experience: exploration, exploitation, and R&D project performance," Strategic Management Journal, Wiley Blackwell, vol. 31(7), pages 734-758, July.
    33. Boh, Wai Fong & Evaristo, Roberto & Ouderkirk, Andrew, 2014. "Balancing breadth and depth of expertise for innovation: A 3M story," Research Policy, Elsevier, vol. 43(2), pages 349-366.
    34. Melero, Eduardo & Palomeras, Neus, 2015. "The Renaissance Man is not dead! The role of generalists in teams of inventors," Research Policy, Elsevier, vol. 44(1), pages 154-167.
    35. Nightingale, Paul, 2000. "Economies of Scale in Experimentation: Knowledge and Technology in Pharmaceutical R&D," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 9(2), pages 315-359, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Gennaro Strazzullo & William J. Ion & Jillian MacBryde, 2022. "An Investigation of the Translational Asset: A Proposed Classification," Journal of the Knowledge Economy, Springer;Portland International Center for Management of Engineering and Technology (PICMET), vol. 13(4), pages 3123-3149, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jong, Simcha & Slavova, Kremena, 2014. "When publications lead to products: The open science conundrum in new product development," Research Policy, Elsevier, vol. 43(4), pages 645-654.
    2. Simeth, Markus & Raffo, Julio D., 2013. "What makes companies pursue an Open Science strategy?," Research Policy, Elsevier, vol. 42(9), pages 1531-1543.
    3. Simeth, Markus & Lhuillery, Stephane, 2015. "How do firms develop capabilities for scientific disclosure?," Research Policy, Elsevier, vol. 44(7), pages 1283-1295.
    4. Slavova, Kremena & Jong, Simcha, 2021. "University alliances and firm exploratory innovation: Evidence from therapeutic product development," Technovation, Elsevier, vol. 107(C).
    5. Beck, Mathias & Junge, Martin & Kaiser, Ulrich, 2017. "Public Funding and Corporate Innovation," IZA Discussion Papers 11196, Institute of Labor Economics (IZA).
    6. Leone, Maria Isabella & Messeni Petruzzelli, Antonio & Natalicchio, Angelo, 2022. "Boundary spanning through external technology acquisition: The moderating role of star scientists and upstream alliances," Technovation, Elsevier, vol. 116(C).
    7. Jiang, Lin & Clark, Brent B. & Turban, Daniel B., 2023. "Overcoming the challenge of exploration: How decompartmentalization of internal communication enhances the effect of exploration on employee inventive performance," Technovation, Elsevier, vol. 119(C).
    8. Anckaert, Paul-Emmanuel & Cassiman, David & Cassiman, Bruno, 2020. "Fostering practice-oriented and use-inspired science in biomedical research," Research Policy, Elsevier, vol. 49(2).
    9. Soh, Pek-Hooi & Subramanian, Annapoornima M., 2014. "When do firms benefit from university–industry R&D collaborations? The implications of firm R&D focus on scientific research and technological recombination," Journal of Business Venturing, Elsevier, vol. 29(6), pages 807-821.
    10. Hyun Ju Jung, 2020. "Recombination sources and breakthrough inventions: university-developed technology versus firm-developed technology," The Journal of Technology Transfer, Springer, vol. 45(4), pages 1121-1166, August.
    11. Michaël Bikard, 2018. "Made in Academia: The Effect of Institutional Origin on Inventors’ Attention to Science," Organization Science, INFORMS, vol. 29(5), pages 818-836, October.
    12. René Belderbos & Marcelina Grabowska & Stijn Kelchtermans & Bart Leten & Jojo Jacob & Massimo Riccaboni, 2021. "Whither geographic proximity? Bypassing local R&D units in foreign university collaboration," Journal of International Business Studies, Palgrave Macmillan;Academy of International Business, vol. 52(7), pages 1302-1330, September.
    13. Hohberger, Jan, 2016. "Does it pay to stand on the shoulders of giants? An analysis of the inventions of star inventors in the biotechnology sector," Research Policy, Elsevier, vol. 45(3), pages 682-698.
    14. Cassiman, Bruno & Veugelers, Reinhilde & Arts, Sam, 2018. "Mind the gap: Capturing value from basic research through combining mobile inventors and partnerships," Research Policy, Elsevier, vol. 47(9), pages 1811-1824.
    15. Choi, Jin-Uk & Lee, Chang-Yang, 2022. "The differential effects of basic research on firm R&D productivity: The conditioning role of technological diversification," Technovation, Elsevier, vol. 118(C).
    16. Antonio Malva & Stijn Kelchtermans & Bart Leten & Reinhilde Veugelers, 2015. "Basic science as a prescription for breakthrough inventions in the pharmaceutical industry," The Journal of Technology Transfer, Springer, vol. 40(4), pages 670-695, August.
    17. Leten, Bart & Kelchtermans, Stijn & Belderbos, Ren, 2010. "Internal Basic Research, External Basic Research and the Technological Performance of Pharmaceutical Firms," Working Papers 2010/12, Hogeschool-Universiteit Brussel, Faculteit Economie en Management.
    18. Keyvan Vakili & Sarah Kaplan, 2021. "Organizing for innovation: A contingency view on innovative team configuration," Strategic Management Journal, Wiley Blackwell, vol. 42(6), pages 1159-1183, June.
    19. Hanne Peeters & Julie Callaert & Bart Looy, 2020. "Do firms profit from involving academics when developing technology?," The Journal of Technology Transfer, Springer, vol. 45(2), pages 494-521, April.
    20. Jiao, Hao & Wang, Tang & Yang, Jifeng, 2022. "Team structure and invention impact under high knowledge diversity: An empirical examination of computer workstation industry," Technovation, Elsevier, vol. 114(C).

    More about this item

    Keywords

    Basic and applied research; Clinical trials; Translational medicine; Experience in diverse fields; Bio-pharmaceutical industry;
    All these keywords.

    JEL classification:

    • O31 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Innovation and Invention: Processes and Incentives
    • O32 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Management of Technological Innovation and R&D
    • J24 - Labor and Demographic Economics - - Demand and Supply of Labor - - - Human Capital; Skills; Occupational Choice; Labor Productivity

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:respol:v:50:y:2021:i:2:s0048733320302298. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/respol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.